Detalhe da pesquisa
1.
Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults.
Vaccine
; 41(47): 6999-7006, 2023 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884415
2.
Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults.
NPJ Vaccines
; 8(1): 75, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230978